Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
NUTX	NUTEX HEALTH INC	United States	$32.90M	49,695,149	2.03%	97.97%	Net Buying
OSCR	OSCAR HEALTH INC	United States	$4.03B	229,727,201	65.61%	24.85%	Net Selling	Net Selling
PIII	P3 HEALTH PARTNERS INC	United States	$140.89M	315,903,414	6.86%	93.14%	Net Buying
AXSM	AXSOME THERAPEUTICS INC	United States	$3.40B	47,374,375	71.00%	29.00%	Net Selling	Net Buying
EOLS	EVOLUS INC	United States	$662.30M	57,943,622	71.82%	28.18%	Net Selling	Net Selling
ABBV	ABBVIE INC	United States	$281.96B	1,766,473,359	70.16%	0.15%	Net Selling	Net Selling
ANIX	ANIXA BIOSCIENCES INC	United States	$103.04M	31,899,800	13.83%	84.70%	Net Buying	Net Buying
ITCI	INTRA-CELLULAR THERAPIES INC	United States	$7.09B	96,807,191	78.45%	21.55%	Net Selling	Net Selling
TECH	BIO-TECHNE CORP	United States	$10.07B	157,191,685	97.66%	2.34%	Net Buying	Net Selling
GLPG	GALAPAGOS NV	Belgium	$1.90B	65,897,071	30.01%	0.00%
LIFE	ATYR PHARMA INC	United States	$106.37M	67,750,024	60.86%	22.55%	Net Buying	Net Selling
FULC	FULCRUM THERAPEUTICS INC	United States	$442.22M	61,935,171	64.02%	35.98%	Net Buying	Net Buying
LEGN	LEGEND BIOTECH CORP	United States	$8.24B	363,822,069	23.61%	0.00%
ZLAB	ZAI LAB LTD	China	$1.58B	992,087,430	4.15%	1.96%	Net Buying	Net Buying
TWST	TWIST BIOSCIENCE CORP	United States	$1.82B	57,818,022	88.25%	11.75%	Net Selling	Net Selling
MRK	MERCK & CO INC	United States	$332.28B	2,532,643,872	76.17%	0.19%	Net Buying	Net Selling
EDIT	EDITAS MEDICINE INC	United States	$435.25M	81,813,850	64.04%	35.96%	Net Selling	Net Selling
ARGX	ARGENX SE	Belgium	$22.07B	59,194,488	55.29%	0.00%
NURO	NEUROMETRIX INC	United States	$8.82M	1,986,540	0.64%	99.36%	Net Buying	Net Buying
NRBO	NEUROBO PHARMACEUTICALS INC	United States	$15.40M	4,906,032	0.25%	99.75%
HQY	HEALTHEQUITY INC	United States	$6.92B	86,158,631	61.02%	38.98%	Net Selling	Net Selling
MRUS	MERUS NV	Netherlands	$2.61B	57,878,284	87.00%	13.00%	Net Selling
LUNG	PULMONX CORP	United States	$280.55M	38,537,356	86.31%	13.69%	Net Selling	Net Selling
UHS	UNIVERSAL HEALTH SERVICES INC	United States	$11.16B	67,221,337	85.92%	10.91%	Net Selling	Net Buying
BOLT	BOLT BIOTHERAPEUTICS INC	United States	$42.32M	38,127,740	54.74%	45.26%	Net Selling
COO	COOPER COMPANIES INC	United States	$17.66B	198,756,284	24.31%	0.86%	Net Selling	Net Selling
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	China	$16.26M	23,940,000	1.22%	0.00%
XBIO	XENETIC BIOSCIENCES INC	United States	$6.30M	1,540,684	0.42%	99.58%
SLGL	SOL-GEL TECHNOLOGIES LTD	Israel	$24.79M	27,857,620	28.59%	0.00%
FUSN	FUSION PHARMACEUTICALS INC	Canada	$1.81B	84,692,585	71.20%	28.80%
FATE	FATE THERAPEUTICS INC	United States	$377.10M	99,237,508	61.86%	38.14%	Net Selling	Net Selling
ACIU	AC IMMUNE SA	Switzerland	$233.11M	99,197,829	29.88%	0.00%
ZOM	ZOMEDICA CORP	United States	$130.33M	979,949,668	8.89%	6.87%	Net Buying
RXST	RXSIGHT INC	United States	$1.95B	36,987,556	70.19%	29.81%	Net Selling	Net Selling
TRAW	TRAWS PHARMA INC	United States	$13.07M	21,040,645	5.95%	94.05%	Net Selling	Net Selling
MTD	METTLER TOLEDO INTERNATIONAL INC	United States	$26.59B	21,478,705	94.58%	4.52%	Net Selling	Net Buying
MASI	MASIMO CORP	United States	$7.20B	52,913,166	83.94%	16.06%	Net Buying	Net Selling
IGMS	IGM BIOSCIENCES INC	United States	$552.59M	58,786,588	37.27%	54.63%	Net Buying	Net Buying
AEMD	AETHLON MEDICAL INC	United States	$3.56M	2,620,399	0.16%	99.84%	Net Buying	Net Buying
MRKR	MARKER THERAPEUTICS INC	United States	$38.19M	8,902,897	1.30%	98.70%
BCYC	BICYCLE THERAPEUTICS PLC	United Kingdom	$967.98M	42,586,185	54.60%	45.40%	Net Selling	Net Selling
CLNN	CLENE INC	United States	$43.67M	128,430,098	9.06%	52.75%	Net Buying	Net Selling
WAT	WATERS CORP	United States	$18.43B	59,202,626	92.46%	7.54%	Net Selling	Net Selling
AMS	AMERICAN SHARED HOSPITAL SERVICES	United States	$20.07M	6,330,000	16.56%	83.44%
ZVRA	ZEVRA THERAPEUTICS INC	United States	$196.29M	43,426,186	29.20%	27.84%	Net Buying
DCPH	DECIPHERA PHARMACEUTICALS INC	United States	$1.18B	80,800,062	67.07%	32.93%	Net Buying	Net Buying
ALHC	ALIGNMENT HEALTHCARE INC	United States	$984.57M	188,977,667	31.34%	68.66%	Net Selling	Net Selling
AGL	AGILON HEALTH INC	United States	$2.05B	409,541,664	80.79%	19.21%	Net Selling	Net Selling
TXG	10X GENOMICS INC	United States	$3.29B	119,166,544	80.47%	15.52%	Net Buying	Net Selling
VERV	VERVE THERAPEUTICS INC	United States	$515.09M	83,619,279	62.25%	37.75%	Net Buying	Net Selling
NYXH	NYXOAH SA	Belgium	$304.52M	28,673,985	7.33%	0.00%
JANX	JANUX THERAPEUTICS INC	United States	$2.45B	51,660,060	54.14%	45.86%	Net Buying
PROC	PROCAPS GROUP SA	Luxembourg	$307.67M	112,824,183	0.22%	76.27%
TMDX	TRANSMEDICS GROUP INC	United States	$3.01B	32,715,316	77.97%	22.03%	Net Selling	Net Selling
NNOX	NANO-X IMAGING LTD	Israel	$517.70M	57,778,628	22.32%	0.00%
SPRY	ARS PHARMACEUTICALS INC	United States	$805.79M	96,501,554	43.67%	56.33%	Net Buying	Net Buying
ARDX	ARDELYX INC	United States	$1.49B	232,686,008	38.01%	61.99%	Net Selling	Net Selling
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	United Kingdom	$97.30M	38,921,212	24.97%	54.37%	Net Buying
RVMD	REVOLUTION MEDICINES INC	United States	$5.92B	164,690,408	89.46%	10.54%	Net Selling	Net Selling
PLRX	PLIANT THERAPEUTICS INC	United States	$711.42M	60,239,176	70.74%	29.26%	Net Selling
UFPT	UFP TECHNOLOGIES INC	United States	$1.63B	7,641,883	82.80%	17.20%	Net Selling	Net Selling
PDEX	PRO DEX INC	United States	$65.59M	3,511,253	5.91%	94.09%	Net Buying
RYTM	RHYTHM PHARMACEUTICALS INC	United States	$2.30B	60,140,495	87.96%	12.04%	Net Selling	Net Selling
SBFM	SUNSHINE BIOPHARMA INC	Canada	$944.80k	994,529	40.70%	59.30%	Net Buying	Net Buying
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	United States	$2.22B	78,219,780	64.83%	35.17%	Net Selling	Net Selling
ALT	ALTIMMUNE INC	United States	$514.70M	70,895,286	34.70%	65.30%	Net Selling	Net Selling
HCSG	HEALTHCARE SERVICES GROUP INC	United States	$799.06M	73,646,450	95.48%	4.52%	Net Buying	Net Buying
CALT	CALLIDITAS THERAPEUTICS AB	Sweden	$580.94M	59,580,087	1.42%	0.00%
ZYME	ZYMEWORKS INC	Canada	$582.89M	70,568,222	61.32%	38.68%	Net Buying
GRFS	GRIFOLS SA	United States	$4.39B	687,554,908	17.73%	0.00%
BGNE	BEIGENE LTD	Cayman Islands	$16.08B	1,359,513,224	3.31%	34.70%	Net Selling	Net Selling
SPRB	SPRUCE BIOSCIENCES INC	United States	$28.80M	41,149,160	63.59%	36.41%	Net Selling	Net Selling
TOI	ONCOLOGY INSTITUTE INC	United States	$85.46M	74,312,921	24.73%	58.31%	Net Selling	Net Selling
PRCT	PROCEPT BIOROBOTICS CORP	United States	$2.64B	50,964,211	65.48%	34.52%	Net Selling	Net Buying
SERA	SERA PROGNOSTICS INC	United States	$348.58M	32,425,661	34.04%	21.12%	Net Selling	Net Selling
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	United States	$14.90M	21,591,119	7.67%	34.34%	Net Buying	Net Buying
EYPT	EYEPOINT PHARMACEUTICALS INC	United States	$834.67M	49,830,792	20.11%	79.89%	Net Selling	Net Buying
ITOS	ITEOS THERAPEUTICS INC	United States	$387.11M	35,843,131	62.37%	37.63%	Net Selling
RCEL	AVITA MEDICAL INC	United States	$219.02M	25,706,662	27.60%	3.35%	Net Buying	Net Buying
INNV	INNOVAGE HOLDING CORP	United States	$531.37M	135,899,435	4.67%	95.33%	Net Selling	Net Selling
NARI	INARI MEDICAL INC	United States	$2.23B	57,960,555	78.21%	21.79%	Net Selling	Net Selling
EDAP	EDAP TMS SA	France	$270.12M	37,103,779	42.93%	0.00%
MREO	MEREO BIOPHARMA GROUP PLC	United Kingdom	$384.31M	701,287,029	11.20%	4.59%
SAGE	SAGE THERAPEUTICS INC	United States	$823.89M	60,182,031	71.61%	28.39%	Net Selling
OCS	OCULIS HOLDING AG	Switzerland	$440.53M	36,649,705	10.87%	0.00%
CVAC	CUREVAC NV	Germany	$521.89M	223,988,675	9.83%	0.00%
IQV	IQVIA HOLDINGS INC	United States	$42.63B	181,500,000	53.95%	46.05%	Net Selling	Net Selling
KRRO	KORRO BIO INC	United States	$504.82M	8,021,946	18.90%	81.10%	Net Buying	Net Buying
VRDN	VIRIDIAN THERAPEUTICS INC	United States	$808.45M	62,767,570	67.46%	32.54%	Net Buying
BFLY	BUTTERFLY NETWORK INC	United States	$162.14M	208,134,212	37.79%	44.10%	Net Selling	Net Selling
STTK	SHATTUCK LABS INC	United States	$502.76M	47,474,783	56.96%	26.49%	Net Selling	Net Selling
VCYT	VERACYTE INC	United States	$1.45B	75,067,823	64.44%	35.56%	Net Selling	Net Selling
CRNX	CRINETICS PHARMACEUTICALS INC	United States	$2.93B	69,596,202	85.00%	15.00%	Net Selling	Net Selling
IMTX	IMMATICS NV	Germany	$847.42M	84,657,789	58.58%	0.00%
IMCR	IMMUNOCORE HOLDINGS PLC	United Kingdom	$2.91B	49,820,613	75.26%	0.07%	Net Buying	Net Buying
CMRX	CHIMERIX INC	United States	$80.29M	89,210,356	45.42%	31.91%	Net Buying	Net Selling
IFRX	INFLARX NV	Germany	$78.31M	58,883,272	29.00%	0.00%
HLN	HALEON PLC	United Kingdom	$39.02B	9,234,573,831	4.42%	0.00%
APRE	APREA THERAPEUTICS INC	United States	$28.24M	5,430,215	1.54%	98.46%	Net Buying	Net Buying
QSI	QUANTUM-SI INC	United States	$233.92M	141,769,917	36.43%	63.57%	Net Buying	Net Buying

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	682	+1.20%	+1.13%	-9.62%	-22.18%	14.88x	5.85x	-68.98%	+2.75%	+21.30%	+91.72%	Strong Buy
Diagnostics & Research	66	+0.75%	+4.09%	-5.10%	-0.74%	38.49x	4.18x	-21.75%	+6.53%	+11.20%	+10.85%	Buy
Drug Manufacturers - General	17	+0.34%	+1.38%	-4.08%	+12.78%	159.81x	6.13x	+32.60%	+7.65%	+14.35%	+15.95%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.98%	+2.24%	-2.72%	-6.94%	33.92x	2.09x	+11.56%	+2.78%	+5.22%	+37.77%	Strong Buy
Healthcare Plans	12	-0.85%	-2.11%	-4.78%	+3.59%	18.86x	2.91x	+20.02%	+6.15%	+14.19%	+16.44%	Buy
Health Information Services	61	+0.87%	+0.45%	-8.40%	-24.77%	72.49x	3.38x	+6.61%	+2.33%	+5.91%	+38.22%	Buy
Medical Care Facilities	50	-0.63%	-0.25%	-6.53%	+3.06%	-1.17x	4.49x	-87.35%	+6.17%	+13.08%	+19.34%	Buy
Medical Devices	154	+0.28%	+1.14%	-4.31%	-15.96%	28.63x	3.70x	+10.75%	+5.35%	+7.78%	+22.71%	Buy
Medical Distribution	9	+0.52%	+1.70%	-0.69%	+37.51%	26.24x	147.94x	+18.14%	+3.52%	+19.64%	+3.58%	Buy
Medical Instruments & Supplies	56	+1.23%	+1.70%	-4.37%	-11.53%	48.29x	3.53x	+11.70%	+7.83%	+10.36%	+19.66%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top healthcare stock with a Zen Score of 75, which is 50 points higher than the healthcare sector average of 25. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other healthcare stocks by -20 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other healthcare stocks by 3 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.61% over the past year, overperforming other healthcare stocks by 10 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.84%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 55 percentage points higher than the healthcare sector average of 2.84%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.95%, which is 9 percentage points higher than the healthcare sector average of 2.84%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.62% in the last day, and up 1.39% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -53.19% in the past year. It has underperformed other stocks in the healthcare sector by -43 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -40.25% in the past year. It has underperformed other stocks in the healthcare sector by -30 percentage points.

3. Orasure Technologies (NASDAQ:OSUR)

Orasure Technologies (NASDAQ:OSUR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has dropped -19.88% in the past year. It has underperformed other stocks in the healthcare sector by -10 percentage points.

Are healthcare stocks a good buy now?

47.45% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.39% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 74.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.